scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1010936447 |
P356 | DOI | 10.1007/S00296-012-2504-3 |
P698 | PubMed publication ID | 22955798 |
P50 | author | Eloisa Bonfa | Q37837127 |
P2093 | author name string | Sandra Gofinet Pasoto | |
Cleonice Bueno | |||
Elaine Pires Leon | |||
Henrique Pires Chakkour | |||
Margarete Borges Gualhardo Vendramini | |||
Mauricio Levy Neto | |||
Renato Romera Natalino | |||
Vilma Dos Santos Trindade Viana | |||
P2860 | cites work | Changes in Epstein-Barr virus antibody titers associated with aging | Q45838703 |
Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjögren's syndrome | Q45841151 | ||
Detection of Epstein-Barr virus DNA by in Situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome | Q45855334 | ||
Detection of the tax gene of HTLV-I in labial salivary glands from patients with Sjögren's syndrome and other diseases of the oral cavity. | Q55239951 | ||
Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome | Q56907597 | ||
Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjögren's syndrome using degenerated consensus PCR primers | Q58004106 | ||
Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal | Q69928846 | ||
Rheumatic disease patients, prone to Sjögren's syndrome and/or lymphoma, mount an antibody response to BHRF1, the Epstein-Barr viral homologue of BCL-2 | Q71843616 | ||
Adequate sampling in cryoglobulinaemia: recommended warmly | Q73124369 | ||
Sjögren's syndrome | Q79911823 | ||
Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome | Q80367281 | ||
Association of Epstein-Barr virus with systemic lupus erythematosus - effect modification by race, age, and cytotoxic T lymphocyte-associate antigen 4 genotype | Q23911107 | ||
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay | Q30775402 | ||
Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry | Q33364289 | ||
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus | Q33993288 | ||
Epstein-Barr virus induces erosive arthritis in humanized mice | Q34058760 | ||
Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil | Q34114546 | ||
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome | Q34117422 | ||
Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression | Q34126659 | ||
Role of viruses in systemic lupus erythematosus and Sjögren syndrome | Q34404100 | ||
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 | ||
Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias | Q34723026 | ||
Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients | Q34778403 | ||
Epstein-Barr virus in autoimmune diseases | Q34887020 | ||
Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. | Q34981036 | ||
Epstein-Barr virus-recent advances | Q35076846 | ||
The curiously suspicious: a role for Epstein-Barr virus in lupus | Q36677016 | ||
Sjögren's syndrome--study of autoantigens and autoantibodies | Q36997269 | ||
Epstein-Barr virus behavior in different populations and implications for control of Epstein-Barr virus-associated tumors | Q38893630 | ||
Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. | Q39452552 | ||
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. | Q39517698 | ||
Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas | Q40491223 | ||
Amplification of Epstein-Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjögren's syndrome patients | Q41201388 | ||
Antibodies to Epstein-Barr virus and cytomegalovirus in primary Sjogren's syndrome | Q41338909 | ||
Comparison of commercial ELISA for detection of antibodies to the viral capsid antigen (VCA) of Epstein-Barr virus (EBV). | Q41745057 | ||
Search for Anti-EA(D) Antibodies in Subjects with an "Isolated VCA IgG" Pattern | Q41854842 | ||
Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjögren's syndrome | Q44220706 | ||
Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study. | Q45374201 | ||
Prevalence of Epstein-Barr virus reactivation in pregnancy | Q45376840 | ||
Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease | Q45381481 | ||
Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2. | Q45399452 | ||
Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years | Q45773968 | ||
Sex difference in the serostatus of adults to the Epstein-Barr virus | Q45781989 | ||
P433 | issue | 5 | |
P304 | page(s) | 1149-1157 | |
P577 | publication date | 2012-09-06 | |
P1433 | published in | Rheumatology International | Q15763689 |
P1476 | title | EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement? | |
P478 | volume | 33 |